Design Lab panel recap June 10–11, Adaptive Reimbursement was explored at the NEWDIGS LEAPS Design Lab by a panel representing a national provider system, commercial payers, a global biopharmaceutical company, … Read More
LEAPS Monthly Recap: may 2020
LEAPS JUNE VIRTUAL DESIGN LABTwo exciting new confirmed developments New Session: Real World Platform Strategies Through the Lens of a Pandemic The ongoing pandemic has generated a flurry of innovation as … Read More
FoCUS Monthly Recap: may 2020
NEW RESOURCES Paying for Cures Toolkit updated with new material for patients and developers Version 2 of the free online resource adds new sections for patients and developers, and provides … Read More
Special sessions announced for LEAPS Design Lab
The LEAPS Virtual Design Lab will be held online June 9–10 by invitation only. If you are interested in attending the panel session, please contact easmall@mit.edu. New Session: Real World Platform Strategies … Read More
FoCUS Monthly Recap: April 2020
SURVEY SAYS— Payer Perspectives on Gene Therapy Reimbursement Results and analysis of the second of two surveys conducted by the FoCUS Project to reveal present payer perspectives regarding current and future … Read More
LEAPS Monthly Recap: April 2020
W2O named first LEAPS Pioneer Site The leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector will help to advance the LEAPS community’s understanding of patterns of variability in … Read More
FoCUS Project teams with the National Pharmaceutical Council (NPC) to explore Medicaid Best Price reforms
FoCUS and NPC plan to explore Medicaid Best Price reforms required to enable precision financing solutions, including analyzing potential adverse effects on Medicaid. The research will combine a review of … Read More
W2O Named First Pioneer Site for MIT NEWDIGS Initiative
Firm Joins Program for Learning Ecosystems Accelerator for Patient-Centered, Sustainable Innovation (LEAPS) Project to Use Data to Improve the Lives of Patients CAMBRIDGE, MA April 30, 2020 – W2O, the leading … Read More
Payer Perspectives on Gene Therapy Reimbursement
J.F. Barlow; M.W. Courtney; M. Trusheim. Pharmaceutical Executive, 04/2020 The reimbursement of emerging durable and potentially curative cell and gene therapies challenge US payers due to their high upfront costs. … Read More
LEAPS Monthly Recap: March 2020
NEW MEMBER Cytel joins NEWDIGS Initiative at MIT as a Strategic Partner Cytel initially will participate in the new LEAPS project’s Adaptive Point-of-Care (APoC) platform to bring prospective, real-world evidence … Read More